PYLERA 140 mg/125 mg/125 mg, hard capsule 120 capsules
Active ingredients: Tetracycline hydrochloride, Metronidazole, Bismuth oxide, Bismuth subcitrate potassium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Hard capsule120 capsulesorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- PYLERA 140 mg/125 mg/125 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s)
- Marketing authorisation holder
- LABORATOIRES JUVISE PHARMACEUTICALS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Apr 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63941426CIP72180420CIP133400921804201Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTRONIDAZOLEgélule | 125 mg · une gélule | SA |
| OXYDE DE BISMUTHgélule | 40 mg · une gélule | FT |
| CHLORHYDRATE DE TÉTRACYCLINEgélule | 125 mg · une gélule | SA |
| SOUS-CITRATE DE BISMUTH POTASSIQUEgélule | 140 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.